The effect of exercise on obesity, body fat distribution and risk for type 2 diabetes

Medicine and Sport Science

Volumn 60, Issue , 2014, Pages 82-93

  Goedecke, Julia H ^a,c   Micklesfield, Lisa K ^b,c  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84958114827     PISSN: 02545020     EISSN: 16622812     Source Type: Book Series    
DOI: 10.1159/000357338     Document Type: Article

References (103)

1. Shaw JE, Sicree RA, Zimmet PZ: Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010; 87: 4-14.
2. Malik VS, Willett WC, Hu FB: Global obesity: trends, risk factors and policy implications. Nat Rev Endocrinol 2012; 9: 13-27.
3. Venables MC, Jeukendrup AE: Physical inactivity and obesity: links with insulin resistance and type 2 diabetes mellitus. Diabetes Metab Res Rev 2009; 25:S18-S23.
4. Vague J: The degree of masculine differentiation of obesities a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am J Clin Nutr 1956; 4: 20-34.
5. Group DPPR: 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 2009; 374: 1677-1686.
6. Carey VJ, Walters EE, Colditz GA, et al: Body fat distribution and risk of noninsulin-dependent diabetes mellitus in women. The Nurses' Health Study. A J Epidemiol 1997; 145: 614-619.
7. Ohlson LO, Larsson B, Svardsudd K, et al: The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes 1985; 34: 1055-1058.
8. Wang Y, Rimm EB, Stampfer MJ, Willett WC, Hu FB: Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr 2005; 81: 555-563.
9. Preis SR, Massaro JM, Robins SJ, et al: Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham Heart Study. Obesity 2009; 18: 2191-2198.
10. Gallagher D, Kelley DE, Yim J-E, et al: Adipose tissue distribution is different in type 2 diabetes. Am J Clin Nutr 2009; 89: 807-814.
11. McLaughlin T, Lamendola C, Liu A, Abbasi F: Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity. J Clin Endocrinol Metab 2011; 96:E1756-E1760.
12. Neeland IJ, Turer AT, Ayers CR, et al: Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. JAMA 2012; 308: 1150-1159.
13. Richelsen B, Pedersen SB, Moller-Pedersen T, Bak JF: Regional differences in triglyceride breakdown in human adipose tissue: effects of catecholamines, insulin, and prostaglandin E2. Metab Clin Exp 1991; 40: 990-996.
14. Goedecke JH, Wake DJ, Levitt NS, et al: Glucocorticoid metabolism within superficial subcutaneous rather than visceral adipose tissue is associated with features of the metabolic syndrome in South African women. Clin Endocrinol (Oxf) 2006; 65: 81-87.
15. Gauthier M-S, O'Brien EL, Bigornia S, et al: Decreased AMP-activated protein kinase activity is associated with increased inflammation in visceral adipose tissue and with whole-body insulin resistance in morbidly obese humans. Biochem Biophys Res Commun 2011; 404: 382-387.
16. Alvehus M, Burén J, Sjöström M, Goedecke J, Olsson T: The human visceral fat depot has a unique inflammatory profile. Obesity 2009; 18: 879-883.
17. Lee M-J, Wu Y, Fried SK: Adipose tissue heterogeneity: implication of depot differences in adipose tissue for obesity complications. Mol Aspects Med 2013; 34: 1-11.
18. Wilding JPH: The importance of free fatty acids in the development of Type 2 diabetes. Diabet Med 2007; 24: 934-945.
19. Foster MT, Pagliassotti MJ: Metabolic alterations following visceral fat removal and expansion: beyond anatomic location. Adipocyte 2012; 1: 192-199.
20. Shay CM, Carnethon MR, Church TR, et al: Lower extremity fat mass is associated with insulin resistance in overweight and obese individuals: The CARDIA Study. Obesity 2011; 19: 2248-2253.
21. Snijder M, Dekker J, Visser M, et al: Associations of hip and thigh circumferences independent of waist circumference with the incidence of type 2 diabetes: The Hoorn Study. Am J Clin Nutr 2003; 77: 1192-1197.
22. Snijder MB, Dekker JM, Visser M, et al: Trunk fat and leg fat have independent and opposite associations with fasting and postload glucose levels: The Hoorn study. Diabetes Care 2004; 27: 372-377.
23. Manolopoulos KN, Karpe F, Frayn KN: Gluteofemoral body fat as a determinant of metabolic health. Int J Obes Relat Metab Disord 2010; 34: 949-959.
24. Snijder MB, Visser M, Dekker JM, et al: Low subcutaneous thigh fat is a risk factor for unfavourable glucose and lipid levels, independently of high abdominal fat. The Health ABC Study. Diabetologia 2005; 48: 301-308.
25. Votruba SB, Jensen MD: Sex differences in abdominal, gluteal, and thigh LPL activity. Am J Physiol Endocrinol Metab 2007; 292:E1823-E1828.
26. Manolopoulos KN, Karpe F, Frayn KN: Marked resistance of femoral adipose tissue blood flow and lipolysis to adrenaline in vivo. Diabetologia 2012; 55: 3029-3037.
27. Tittelbach TJ, Berman DM, Nicklas BJ, Ryan AS, Goldberg AP: Racial differences in adipocyte size and relationship to the metabolic syndrome in obese women. Obes Res 2004; 12: 990-998.
28. Hwang JH, Stein DT, Barzilai N, et al: Increased intrahepatic triglyceride is associated with peripheral insulin resistance: in vivo MR imaging and spectroscopy studies. Am J Physiol Endocrinol Metab 2007; 293:E1663-E1669.
29. Karelis AD: Metabolic and body composition factors in subgroups of obesity: what do we know? J Clin Endocrinol Metab 2004; 89: 2569-2575.
30. Conus F, Rabasa-Lhoret R, Péronnet F: Characteristics of metabolically obese normal-weight (MONW) subjects. Appl Physiol Nutr Metab 2007; 32: 4-12.
31. Samocha-Bonet D, Chisholm DJ, Tonks K, Campbell LV, Greenfield JR: Insulinsensitive obesity in humans-A 'favorable fat' phenotype? Trends Endocrinol Metab 2012; 23: 116-124.
32. Storlien L, Oakes ND, Kelley DE: Metabolic flexibility. Proc Nutr Soc 2007; 63: 363-368.
33. Blüher M: Are there still healthy obese patients? Curr Opin Endocrinol Diabetes Obes 2012; 19: 341-346.
34. Kruger H, Venter C, Vorster H, Margetts B: Physical inactivity is the major determinant of obesity in black women in the North West Province, South Africa: The THUSA study. Nutrition 2002; 18: 422-427.
35. Cook I, Alberts M, Lambert EV: Relationship between adiposity and pedometer-assessed ambulatory activity in adult, rural African women. Int J Obes 2008; 32: 1327-1330.
36. Friedenreich CM, Woolcott CG, McTiernan A, et al: Adiposity changes after a 1-year aerobic exercise intervention among postmenopausal women: A randomized controlled trial. Int J Obes 2010; 35: 427-435.
37. Slentz CA, Duscha BD, Johnson JL, et al: Effects of the amount of exercise on body weight, body composition, and measures of central obesity: STRRIDE-A randomized controlled study. Arch Intern Med 2004; 164: 31-39.
38. Giannopoulou I: Exercise is required for visceral fat loss in postmenopausal women with type 2 diabetes. J Clin Endocrinol Metab 2004; 90: 1511-1518.
39. Janssen I, Fortier A, Hudson R, Ross R: Effects of an energy-restrictive diet with or without exercise on abdominal fat, intermuscular fat, and metabolic risk factors in obese women. Diabetes Care 2002; 25: 431-438.
40. Borel A-L, Nazare J-A, Smith J, et al: Visceral and not subcutaneous abdominal adiposity reduction drives the benefits of a 1-year lifestyle modification program. Obesity 2012; 20: 1223-1233.
41. Ross R, Janssen I, Dawson J, et al: Exercise-induced reduction in obesity and insulin resistance in women: A randomized controlled trial. Obes Res 2004; 12: 789-798.
42. Thompson D, Karpe F, Lafontan M, Frayn K: Physical activity and exercise in the regulation of human adipose tissue physiology. Physiol Rev 2012; 92: 157-191.
43. Vissers D, Hens W, Taeymans J, Baeyens J-P, Poortmans J, Van Gaal L: The effect of exercise on visceral adipose tissue in overweight adults: A systematic review and meta-analysis. PLoS One 2013; 8:e56415.
44. Hunter GR, Chandler-Laney PC, Brock DW, Lara-Castro C, Fernández JR, Gower BA: Fat distribution, aerobic fitness, blood lipids, and insulin sensitivity in African-American and European-American women. Obesity 2009; 18: 274-281.
45. Hawley JA: Exercise as a therapeutic intervention for the prevention and treatment of insulin resistance. Diabetes Metab Res Rev 2004; 20: 383-393.
46. Yoshioka M, Doucet E, St-Pierre S, et al: Impact of high-intensity exercise on energy expenditure, lipid oxidation and body fatness. Int J Obes Relat Metab Disord 2001; 25: 332-339.
47. Bajpeyi S, Tanner CJ, Slentz CA, et al: Effect of exercise intensity and volume on persistence of insulin sensitivity during training cessation. J Appl Physiol 2009; 106: 1079-1085.
48. Horowitz JF: Fatty acid mobilization from adipose tissue during exercise. Trends Endocrinol Metab 2003; 14: 386-392.
49. Irving BA, Davis CK, Brock DW, et al: Effect of exercise training intensity on abdominal visceral fat and body composition. Med Sci Sports Exerc 2008; 40: 1863-1872.
50. Irwin ML, Yasui Y, Ulrich CM, et al: Effect of exercise on total and intra-abdominal body fat in postmenopausal women: A randomized controlled trial. JAMA 2003; 289: 323-330.
51. McTiernan A, Sorensen B, Irwin ML, et al: Exercise effect on weight and body fat in men and women. Obesity (Silver Spring) 2007; 15: 1496-1512.
52. Slentz CA: Inactivity, exercise, and visceral fat. STRRIDE: A randomized, controlled study of exercise intensity and amount. J Appl Physiol 2005; 99: 1613-1618.
53. Ohkawara K, Tanaka S, Miyachi M, Ishikawa-Takata K, Tabata I: A doseresponse relation between aerobic exercise and visceral fat reduction: systematic review of clinical trials. Int J Obes 2007; 31: 1786-1797.
54. Larson-Meyer DE, Redman L, Heilbronn LK, Martin CK, Ravussin E: Caloric restriction with or without exercise. Med Sci Sports Exerc 2010; 42: 152-159.
55. Ross R, Bradshaw AJ: The future of obesity reduction: beyond weight loss. Nature Rev Endocrinol 2009; 5: 319-325.
56. Ainsworth BE, Haskell WL, Whitt MC, et al: Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000; 32:S498-S504.
57. Slentz CA, Bateman LA, Willis LH, et al: Effects of aerobic vs. resistance training on visceral and liver fat stores, liver enzymes, and insulin resistance by HOMA in overweight adults from STRRIDE AT/ RT. Am J Physiol Endocrinol Metab 2011; 301:E1033-E1039.
58. Willis LH, Slentz CA, Bateman LA, et al: Effects of aerobic and/or resistance training on body mass and fat mass in overweight or obese adults. J Appl Physiol 2012; 113: 1831-1837.
59. Lynch NA, Nicklas BJ, Berman DM, Dennis KE, Goldberg AP: Reductions in visceral fat during weight loss and walking are associated with improvements in VO(2 max). J Appl Physiol 2001; 90: 99-104.
60. Wong SL, Katzmarzyk PT, Nichaman MZ, Church TS, Blair SN, Ross R: Cardiorespiratory fitness is associated with lower abdominal fat independent of body mass index. Med Sci Sports Exerc 2004; 36: 286-291.
61. Janssen I, Katzmarzyk P, Ross R, et al: Fitness alters the associations of BMI and waist circumference with total and abdominal fat. Obes Res 2004; 12: 525-537.
62. Arsenault BJ, Lachance D, Lemieux I, et al: Visceral adipose tissue accumulation, cardiorespiratory fitness, and features of the metabolic syndrome. Arch Intern Med 2007; 167: 1518-1525.
63. De Cocker KA, van Uffelen JGZ, Brown WJ: Associations between sitting time and weight in young adult Australian women. Prev Med 2010; 51: 361-367.
64. Blanck HM, McCullough ML, Patel AV, et al: Sedentary behavior, recreational physical activity, and 7-year weight gain among postmenopausal US women. Obesity 2007; 15: 1578-1588.
65. Thorp AA, Owen N, Neuhaus M, Dunstan DW: Sedentary behaviors and subsequent health outcomes in adults. Am J Prevent Med 2011; 41: 207-215.
66. Proper KI, Singh AS, van Mechelen W, Chinapaw MJM: Sedentary behaviors and health outcomes among adults. Am J Prevent Med 2011; 40: 174-182.
67. Pavey TG, Peeters G, Brown WJ: Sittingtime and 9-year all-cause mortality in older women. Br J Sports Med, E-pub ahead of print.
68. Hu FB, Li TY, Colditz GA, Willett WC, Manson JE: Television watching and other sedentary behaviors in relation to risk of obesity and type 2 diabetes mellitus in women. JAMA 2003; 289: 1785-1791.
69. Olsen RH, Krogh-Madsen R, Thomsen C, Booth FW, Pedersen BK: Metabolic responses to reduced daily steps in healthy nonexercising men. JAMA 2008; 299: 1261-1263.
70. Okura T, Nakata Y, Lee DJ, Ohkawara K, Tanaka K: Effects of aerobic exercise and obesity phenotype on abdominal fat reduction in response to weight loss. Int J Obes 2005; 29: 1259-1266.
71. Hamdy O, Porramatikul S, Al-Ozairi E: Metabolic obesity: The paradox between visceral and subcutaneous fat. Curr Diabetes Rev 2006; 2: 367-373.
72. Goedecke JH, Dave JA, Faulenbach MV, et al: Insulin response in relation to insulin sensitivity: an appropriate beta-cell response in black South African women. Diabetes Care 2009; 32: 860-865.
73. Lovejoy JC, la Bretonne de JA, Klemperer M, Tulley R: Abdominal fat distribution and metabolic risk factors: effects of race. Metab Clin Exp 1996; 45: 1119-1124.
74. Bajaj M, Banerji MA: Type 2 diabetes in South Asians: A pathophysiologic focus on the Asian-Indian epidemic. Curr Diab Rep 2004; 4: 213-218.
75. Kantartzis K, Machann J, Schick F, et al: Effects of a lifestyle intervention in metabolically benign and malign obesity. Diabetologia 2010; 54: 864-868.
76. Hu G, Lindstrom J, Valle TT, et al: Physical activity, body mass index, and risk of type 2 diabetes in patients with normal or impaired glucose regulation. Arch Intern Med 2004; 164: 892.
77. Weinstein AR, Sesso HD, Lee IM, et al: Relationship of physical activity vs body mass index with type 2 diabetes in women. JAMA 2004; 292: 1188-1194.
78. Rana JS, Li TY, Manson JE, Hu FB: Adiposity compared with physical inactivity and risk of type 2 diabetes in women. Diabetes Care 2007; 30: 53-58.
79. Fogelholm M: Physical activity, fitness and fatness: relations to mortality, morbidity and disease risk factors. A systematic review. Obes Rev 2010; 11: 202-221.
80. LaMonte MJ, Blair SN: Physical activity, cardiorespiratory fitness, and adiposity: contributions to disease risk. Curr Opin Clin Nutr Metab Care 2006; 9: 540-546.
81. Gill JMR, Malkova D: Physical activity, fitness and cardiovascular disease risk in adults: interactions with insulin resistance and obesity. Clin Sci 2006; 110: 409.
82. Wei M, Kampert JB, Barlow CE, et al: Relationship between low cardiorespiratory fitness and mortality in normalweight, overweight, and obese men. JAMA 1999; 282: 1547-1553.
83. Lee DC, Sui X, Church TS, Lee IM, Blair SN: Associations of cardiorespiratory fitness and obesity with risks of impaired fasting glucose and type 2 diabetes in men. Diabetes Care 2008; 32: 257-262.
84. Sui X, Hooker SP, Lee IM, et al: A prospective study of cardiorespiratory fitness and risk of type 2 diabetes in women. Diabetes Care 2007; 31: 550-555.
85. Capurso C, Capurso A: From excess adiposity to insulin resistance: The role of free fatty acids. Vasc Pharmacol 2012; 57: 91-97.
86. Frayn KN: Fat as a fuel: emerging understanding of the adipose tissue-skeletal muscle axis. Acta Physiol 2010; 199: 509-518.
87. Weyer C, Foley JE, Bogardus C, Tataranni PA, Pratley RE: Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia 2000; 43: 1498-1506.
88. Hotamisligil GS: Molecular mechanisms of insulin resistance and the role of the adipocyte. Int J Obes Relat Metab Disord 2000; 24(suppl 4):S23-S27.
89. Stefanyk LE, Dyck DJ: The interaction between adipokines, diet and exercise on muscle insulin sensitivity. Curr Opin Clin Nutr Metab Care 2010; 13: 255-259.
90. Simpson KA, Singh MAF: Effects of exercise on adiponectin: A systematic review. Obesity 2008; 16: 241-256.
91. Kloting N, Fasshauer M, Dietrich A, et al: Insulin-sensitive obesity. Am J Physiol Endocrinol Metab 2010; 299:E506-E515.
92. You T, Nicklas BJ: Effects of exercise on adipokines and the metabolic syndrome. Curr Diab Rep 2008; 8: 7-11.
93. Hopps E, Canino B, Caimi G: Effects of exercise on inflammation markers in type 2 diabetic subjects. Acta Diabetol 2011; 48: 183-189.
94. Balducci S, Zanuso S, Nicolucci A, et al: Anti-inflammatory effect of exercise training in subjects with type 2 diabetes and the metabolic syndrome is dependent on exercise modalities and independent of weight loss. Nutr Metab Cardiovasc Dis 2010; 20: 608-617.
95. Stensvold D, Slørdahl SA, Wisløff U: Effect of exercise training on inflammation status among people with metabolic syndrome. Metab Syndr Relat Disord 2012; 10: 267-272.
96. Febbraio MA, Steensberg A, Starkie RL, McConell GK, Kingwell BA: Skeletal muscle interleukin-6 and tumor necrosis factor-alpha release in healthy subjects and patients with type 2 diabetes at rest and during exercise. Metab Clin Exp 2003; 52: 939-944.
97. Pedersen BK, Febbraio MA: Muscle as an endocrine organ: focus on musclederived interleukin-6. Physiol Rev 2008; 88: 1379-1406.
98. Starkie R, Ostrowski SR, Jauffred S, Febbraio M, Pedersen BK: Exercise and IL-6 infusion inhibit endotoxininduced TNF-α production in humans. FASEB J 2003; 17: 884-886.
99. Pedersen BK: The diseasome of physical inactivity and the role of myokines in muscle-fat cross talk. J Physiol 2009; 587: 5559-5568.
100. Hagberg JM, Jenkins NT, Spangenburg E: Exercise training, genetics and type 2 diabetes-related phenotypes. Acta Physiol 2012; 205: 456-471.
101. Rosen ED, Spiegelman BM: PPARgamma: A nuclear regulator of metabolism, differentiation, and cell growth. J Biol Chem 2001; 276: 37731-37734.
102. Deeb SS, Fajas L, Nemoto M, et al: A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 1998; 20: 284-287.
103. Gouda HN, Sagoo GS, Harding AH, Yates J, Sandhu MS, Higgins JPT: The Association between the peroxisome proliferator-activated receptor-2 (PPARG2) Pro12Ala gene variant and type 2 diabetes mellitus: A HuGE review and meta-analysis. Am J Epidemiol 2010; 171: 645-655.